Target Species:
Chickens.
Indications for use
For the active immunisation of chickens for passive immunisation of the progeny of the vaccinated chickens to reduce viraemia and clinical signs of disease caused by avian reovirus (ARV) genotypes 1 and 4.
Onset of immunity:
•4 weeks after booster vaccination
•In progeny: 1 day of age
Duration of immunity:
•80 weeks after booster vaccination
•In progeny: 3 weeks of age
Cross-protection has been established for ARV genotypes 2, 3 and 5.
Contraindications
None.
Special warnings for each target species
Vaccinate healthy animals only.
Special precautions for use
Not applicable.
Operator warnings
To the user:
This veterinary medicinal product contains mineral oil. Accidental injection/self-injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. If you are accidentally injected with this veterinary medicinal product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician:
This veterinary medicinal product contains mineral oil. Even if small amounts have been injected, accidental injection with this veterinary medicinal product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
Adverse Reactions
Chickens:
Uncommon (1 to 10 animals / 1000 animals treated): | Injection site lump1 |
1 Generally disappearing within 3 weeks.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Use during pregnancy or lactation
Do not use in birds in lay and within 3 weeks before the start of the laying period.
Interactions
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case-by-case basis.
Amounts to be administered and administration route
For intramuscular use.
The vaccine is intended for use as a booster vaccination following priming with vaccines against avian reovirus. Primary vaccination should be performed with live vaccine (e.g. Nobilis Reo 1133) or with this vaccine.
- Use as primary vaccination:
Administer a single dose of 0.3 ml in the breast or thigh region from 7 weeks of age onwards.
- Use as booster vaccination:
Administer a single dose of 0.3 ml in the breast or thigh region from 8 weeks of age onwards, but no later than 3 weeks before the onset of lay. The vaccine should be given at least 4 weeks after administration of the primary vaccination.
Before use, allow the vaccine to reach room temperature.
Shake well before use.
Syringes and needles must be sterile before use.
Follow standard aseptic procedures.
Overdose
No adverse reactions other than those mentioned in section 3.6 were observed after the
administration of a double dose of vaccine.
Withdrawal periods
Zero days.